START-UP ADVICE
We’re here to help you tackle your biggest challenges and thrive.
CRS is very active with mentoring university innovation teams and judging hackathons in healthcare. Human-centered design is a method we encourage our life science entrepreneurs and mentees to use to sharpen their ideas.
Have you begun your start-up?
We’ve started several company ventures ourselves and backed-up payroll and other emergency costs. Entrepreneurs understand the grind, highs and lows. We also bring pragmatism and critical-thinking to your toughest problems. We’ve got a wide network who can be accessed for your inquiries.
Let us know what questions keep you up at night.
“Opportunity is missed by most people because it is dressed in overalls and looks like work.”
— THOMAS EDISON
CLINICAL RESEARCH STRATEGIES PROUDLY SUPPORTS LOCAL ACCELERATOR AND INNOVATION ENGINES
M2D2 IMPACT Program!
IMPACT is a 12-week accelerator program that uses a unique 1:1 approach and is created to connect startups with resources needed for commercialization. Selected companies will have the opportunity to engage with our corporate sponsors.
If you participate in the IMPACT Accelerator Program, you’ll access:
- Educational workshops and seminars tailored to your innovation
- Expert mentorship from leaders in the LifeSciences industry
- Prizes and resources worth thousands from healthcare organizations interested in your technology
LifeX – Accelerating Life Sciences
LifeX drives the development and growth of early-stage life science companies … and growth of life sciences startups in Pittsburgh and across the country. LifeX is a capital growth company that de-risks time, resources, and investment for life sciences companies. They focus on the strategic pillars of commercialization, capital, infrastructure, and resources to create alignment and achieve the highest probability of success.
Their culture is made up of individuals who are highly committed to each company as they implement their defined commercialization process specific to their business strategy.